Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
Peter M Ten KloosterLetty G A VersteegMartijn A H Oude VoshaarInmaculada de la TorreFrancesco De LeonardisWalid FakhouriLiliana Zaremba-PechmannMart van de LaarPublished in: Arthritis research & therapy (2019)
Netherlands Trial Register NTR578, 12 January 2006.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- study protocol
- phase iii
- electronic health record
- juvenile idiopathic arthritis
- clinical trial
- phase ii
- high intensity
- big data
- interstitial lung disease
- systemic sclerosis
- artificial intelligence
- deep learning